They also confirmed the ceRNA network of CDKN2B-AS1 in AD, and that CDKN2BAS1 enables STAT3 expression in VSMCs by competitively sponging miR-320d and thus controlling the multiplication and apoptosis of VSMCs (81). This evidence concerns the gene CDKN2B and Alzheimer disease.